Leerink Partners maintained an Outperform rating on Veracyte, Inc (NASDAQ: VCYT), and cut the price target to $11.00 (from $13.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Veracyte (VCYT) Tops Q3 EPS by 1cNovember 5, 2015 5:28 PM Veracyte Announces Third Quarter 2015 Financial ResultsNovember 5, 2015 4:05 PM Trading Radar for 11/5: Disney (DIS), Celgene (CELG), SeaWorld (SEAS), Sprouts (SFM), CyberArk (CYBR) ReportNovember 4, 2015 3:11 PM Veracyte Announces Data to be Presented at PFF Summit 2015 Highlighting IPF Diagnostic Challenges and Potential of New Genomic-Based Testing ApproachesNovember 4, 2015 7:30 AM